{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T19:48:52Z","timestamp":1779392932695,"version":"3.53.1"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-156-04\/503-11-001-19-00"],"award-info":[{"award-number":["503\/1-156-04\/503-11-001-19-00"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["-2019\/35\/D\/NZ7\/02830"],"award-info":[{"award-number":["-2019\/35\/D\/NZ7\/02830"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ejphar.2022.175214","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T22:00:25Z","timestamp":1661205625000},"page":"175214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["The role of kappa opioid receptors in immune system \u2013 An overview"],"prefix":"10.1016","volume":"933","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-6524","authenticated-orcid":false,"given":"Adrian","family":"Szczepaniak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Machelak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Fichna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Zieli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175214_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-5728(95)00159-X","article-title":"Inhibition of primary murine macrophage cytokine production in vitro following treatment with the K-opioid agonist U50,488H","volume":"64","author":"Alicea","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2012.03.014","article-title":"Nociceptin\/orphanin FQ inhibition with SB612111 ameliorates dextran sodium sulfate-induced colitis","author":"Alt","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/acer.13406","article-title":"Role of the dynorphin\/kappa opioid receptor system in the motivational effects of ethanol","author":"Anderson","year":"2017","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.ejphar.2022.175214_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/ALN.0b013e3181af6356","article-title":"Analgesic efficacy of peripheral \u03ba-opioid receptor agonist CR665 Compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain","volume":"111","author":"Arendt-Nielsen","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2022.175214_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neulet.2012.07.018","article-title":"Effects of peripheral \u03ba opioid receptor activation on inflammatory mechanical hyperalgesia in male and female rats","volume":"524","author":"Auh","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2022.175214_bib6","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0306-4522(97)00227-3","article-title":"Cellular localization and distribution of the cloned mu and kappa opioid receptors in rat gastrointestinal tract","volume":"81","author":"Bagnol","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2022.175214_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ph12020095","article-title":"Therapeutic potential of kappa opioid agonists","volume":"12","author":"Beck","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2022.175214_bib8","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-4615-1951-5_2","article-title":"Detection of \u041a-opioid receptor mRNA in immature T cells","author":"Belkowski","year":"1995"},{"key":"10.1016\/j.ejphar.2022.175214_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3182662098","article-title":"Endogenous opioid systems: current concepts and clinical correlations","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2022.175214_bib10","doi-asserted-by":"crossref","DOI":"10.1128\/CDLI.7.5.719-723.2000","article-title":"Detection and function of opioid receptors on cells from the immune system","author":"Bidlack","year":"2000","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib11","series-title":"Journal of Neuroimmune Pharmacology","first-page":"260","article-title":"Opioid receptors and signaling on cells from the immune system","author":"Bidlack","year":"2006"},{"key":"10.1016\/j.ejphar.2022.175214_bib12","doi-asserted-by":"crossref","first-page":"29803","DOI":"10.1074\/jbc.M705540200","article-title":"Long-acting \u03ba opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase","volume":"282","author":"Bruchas","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.175214_bib13","first-page":"971","article-title":"Asimadoline, a \u03ba-opioid agonist","volume":"20","author":"Camilleri","year":"2009","journal-title":"and Visceral Sensation NIH Public Access"},{"key":"10.1016\/j.ejphar.2022.175214_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","article-title":"Depressive-like effects of the \u03ba-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats","volume":"316","author":"Carlezon","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175214_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2004.08.028","article-title":"Pharmacological properties of JDTic: a novel \u03ba-opioid receptor antagonist","volume":"501","author":"Carroll","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib16","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133093","article-title":"IL-4 induces M2 macrophages to produce sustained analgesia via opioids","volume":"5","author":"Celik","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejphar.2022.175214_bib17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0002-9440(10)64466-5","article-title":"Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2","volume":"161","author":"Cenac","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2022.175214_bib18","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1021\/jm990483l","article-title":"Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors: synthesis, biological properties, and antinociceptive activities","volume":"43","author":"Chen","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2022.175214_bib19","article-title":"Inflammatory responses and inflammation-associated diseases in organs","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2022.175214_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10753-011-9329-1","article-title":"Local kappa opioid receptor activation decreases temporomandibular joint inflammation","volume":"35","author":"Chicre-Alc\u00e2ntara","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.ejphar.2022.175214_bib21","doi-asserted-by":"crossref","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a national institutes of health pathways to prevention workshop","author":"Chou","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ejphar.2022.175214_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.bjp.0702266","article-title":"Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4","volume":"126","author":"Cunha","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib23","doi-asserted-by":"crossref","DOI":"10.1186\/1744-8069-8-10","article-title":"Stimulation of peripheral Kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3K\u03b3\/AKT\/nNOS\/NO signaling pathway","volume":"8","author":"Cunha","year":"2012","journal-title":"Mol. Pain"},{"key":"10.1016\/j.ejphar.2022.175214_bib24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2036.2004.01922.x","article-title":"Effect of asimadoline, a \u03ba opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome","volume":"20","author":"Delvaux","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175214_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122563","article-title":"Cellular and oxidative mechanisms associated with interleukin-6 signaling in the vasculature","author":"Didion","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.175214_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/j.1527-3458.2005.tb00270.x","article-title":"Bremazocine: a \u03ba-opioid agonist with potent analgesic and other pharmacologic properties","author":"Dortch-Carnes","year":"2005","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2022.175214_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2016.09.008","article-title":"Topical nalfurafine exhibits anti-inflammatory and anti-pruritic effects in a murine model of AD","author":"Elliott","year":"2016","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.ejphar.2022.175214_bib28","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0024-3205(99)00417-8","article-title":"Potent antinociceptive effects of TRK-820, a novel \u03ba-opioid receptor agonist","volume":"65","author":"Endoh","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2022.175214_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0014-2999(99)00815-8","article-title":"Characterization of the antinociceptive effects of TRK-820 in the rat","volume":"387","author":"Endoh","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib30","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/ibd.21873","article-title":"Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors","volume":"18","author":"Fichna","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.ejphar.2022.175214_bib31","article-title":"Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating \u03ba-opioid and cannabinoid receptors","volume":"21","author":"Fichna","year":"2009","journal-title":"Neuro Gastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2022.175214_bib32","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2022.175214_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ajgsup.2014.5","article-title":"Molecular physiology of enteric opioid receptors","volume":"2","author":"Galligan","year":"2014","journal-title":"Am. J. Gastroenterol. Suppl."},{"key":"10.1016\/j.ejphar.2022.175214_bib34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/164_2016_116","article-title":"Insights into the role of opioid receptors in the GI tract: experimental evidence and therapeutic relevance","volume":"239","author":"Galligan","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib35","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0165-5728(02)00419-8","article-title":"Enhanced humoral response in kappa-opioid receptor knockout mice","volume":"134","author":"Gav\u00e9riaux-Ruff","year":"2003","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib36","doi-asserted-by":"crossref","DOI":"10.2147\/JPR.S127950","article-title":"Management of pain in patients with temporomandibular disorder (TMD): challenges and solutions","author":"Gil-Mart\u00ednez","year":"2018","journal-title":"J. Pain Res."},{"key":"10.1016\/j.ejphar.2022.175214_bib37","doi-asserted-by":"crossref","DOI":"10.1007\/s12079-020-00590-3","article-title":"Opioid receptors signaling network","author":"Gopalakrishnan","year":"2021","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.ejphar.2022.175214_bib38","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.lfs.2005.07.048","article-title":"Comparison of opioid receptor distributions in the rat ileum","volume":"78","author":"Gray","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2022.175214_bib39","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0165-5728(97)00018-0","article-title":"Inhibition of T cell superantigen responses following treatment with the \u03ba-opioid agonist U50,488H","volume":"75","author":"Guan","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AAP.0b013e318274a8a1","article-title":"The \u03ba-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons","volume":"38","author":"Hassan","year":"2013","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.ejphar.2022.175214_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)11434-1","article-title":"Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor- BNI) in the mouse tail-flick test","author":"Horan","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175214_bib42","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12974-016-0696-2","article-title":"Bullatine A stimulates spinal microglial dynorphin A expression to produce anti-hypersensitivity in a variety of rat pain models","volume":"13","author":"Huang","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2022.175214_bib43","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3109\/08923973.2013.767346","article-title":"Remifentanil attenuates human neutrophils activation induced by lipopolysaccharide","volume":"35","author":"Hyejin","year":"2013","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.ejphar.2022.175214_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0165-5728(95)00050-C","article-title":"Enhancement of phagocytosis by dynorphin A in mouse peritoneal macrophages","volume":"60","author":"Ichinose","year":"1995","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00132","article-title":"Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions","volume":"4","author":"Iwaszkiewicz","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00213-010-1803-1","article-title":"Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse","volume":"210","author":"Jackson","year":"2010","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175214_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5055\/jom.2016.0321","article-title":"The emerging therapeutic roles of \u03ba-opioid agonists","volume":"12","author":"Jones","year":"2016","journal-title":"J. Opioid Manag."},{"key":"10.1016\/j.ejphar.2022.175214_bib48","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1523\/JNEUROSCI.5530-09.2010","article-title":"Shared mechanisms for opioid tolerance and a transition to chronic pain","volume":"30","author":"Joseph","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2022.175214_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","author":"Kany","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.175214_bib50","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/B978-0-12-420118-7.00012-3","article-title":"Salvinorin A analogs and other kappa-opioid receptor compounds as treatments for cocaine abuse","author":"Kivell","year":"2014"},{"key":"10.1016\/j.ejphar.2022.175214_bib51","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/j.1476-5381.1987.tb11398.x","article-title":"Pharmacological profile of PD 117302, a selective \u03ba\u2010opioid agonist","volume":"92","author":"Leighton","year":"1987","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib52","first-page":"5","article-title":"Opioid system modulates the immune function: a review","volume":"1","author":"Liang","year":"2016","journal-title":"Transl. Perioper. pain Med."},{"key":"10.1016\/j.ejphar.2022.175214_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00300","article-title":"Opioid receptors in immune and glial cells\u2014implications for pain control","author":"Machelska","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1213\/ANE.0000000000004058","article-title":"Suppression of human natural killer cells by different classes of opioids","volume":"128","author":"Maher","year":"2019","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2022.175214_bib55","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2036.2008.03730.x","article-title":"Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome","volume":"28","author":"Mangel","year":"2008","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2022.175214_bib56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.neuron.2019.02.029","article-title":"Pain-induced negative affect is mediated via recruitment of the nucleus accumbens kappa opioid system","volume":"102","author":"Massaly","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2022.175214_bib57","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1471-4159.2008.05745.x","article-title":"Kappa opioids promote the proliferation of astrocytes via G\u03b2\u03b3 and \u03b2-arrestin 2-dependent MAPK-mediated pathways","volume":"107","author":"McLennan","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2022.175214_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173301","article-title":"Blockade of kappa-opioid receptors amplifies microglia-mediated inflammatory responses","volume":"212","author":"Missig","year":"2022","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2022.175214_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0162-3109(99)00188-5","article-title":"Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response","volume":"47","author":"Miyagi","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.ejphar.2022.175214_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2016.06.048","article-title":"The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception","volume":"1648","author":"Moon","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2022.175214_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00407","article-title":"A review of the therapeutic potential of recently developed G protein-biased kappa agonists","author":"Mores","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib62","doi-asserted-by":"crossref","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","author":"Oishi","year":"2018","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ejphar.2022.175214_bib63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/gut.2005.080887","article-title":"Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation","volume":"55","author":"Philippe","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.ejphar.2022.175214_bib64","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1172\/JCI200316750","article-title":"Anti-inflammatory properties of the \u03bc opioid receptor support its use in the treatment of colon inflammation","volume":"111","author":"Philippe","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2022.175214_bib65","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pharmtox-010715-103042","article-title":"The emerging role of spinal dynorphin in chronic pain: a therapeutic perspective","author":"Podvin","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2022.175214_bib66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1124\/jpet.103.049346","article-title":"The expression of \u03b4- and \u03ba-opioid receptor is enhanced during intestinal inflammation in mice","volume":"306","author":"Pol","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175214_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180014","article-title":"Pain and pain mechanisms in patients with inflammatory arthritis: a Danish nationwide cross-sectional DANBIO registry survey","volume":"12","author":"Rifbjerg-Madsen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2022.175214_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172877","article-title":"Analgesic treatment with buprenorphine should be adapted to the mouse strain","volume":"191","author":"Rudeck","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2022.175214_bib69","article-title":"Systemic administration of sialorphin attenuates experimental colitis in mice via interaction with mu and kappa opioid receptors","author":"Salaga","year":"2017","journal-title":"J. Crohns. Colitis"},{"key":"10.1016\/j.ejphar.2022.175214_bib70","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bcp.2014.09.018","article-title":"Novel orally available salvinorin a analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors","volume":"92","author":"Salaga","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib71","article-title":"Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract","author":"Salaga","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2022.175214_bib72","article-title":"Impact of buprenorphine on learning and memory ability, oxidative status and inflammation in the hippocampus of rat","volume":"13","author":"Samini","year":"2020","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib73","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/281240","article-title":"Vascular inflammation and endothelial dysfunction in experimental hypertension","author":"Savoia","year":"2011","journal-title":"Int. J. Hypertens."},{"key":"10.1016\/j.ejphar.2022.175214_bib74","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s002130051016","article-title":"U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking","volume":"144","author":"Schenk","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175214_bib75","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pain.2008.01.023","article-title":"Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation","volume":"138","author":"Schepers","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.175214_bib76","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pain.2007.07.010","article-title":"Inflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociception","volume":"136","author":"Schepers","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2022.175214_bib77","doi-asserted-by":"crossref","first-page":"22387","DOI":"10.1074\/jbc.M113.476234","article-title":"Functional selectivity of 6\u2032-guanidinonaltrindole (6\u2032-GNTI) at \u03ba-opioid receptors in striatal neurons","volume":"288","author":"Schmid","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.175214_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107638","article-title":"Evaluation of dynorphin and kappa-opioid receptor level in the human blood lymphocytes and plasma: possible role as a biomarker in severe opioid use disorder","volume":"205","author":"Shahkarami","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejphar.2022.175214_bib79","series-title":"Opioid Receptor Expression and Intracellular Signaling by Cells Involved in Host Defense and Immunity","author":"Sharp","year":"2013"},{"key":"10.1016\/j.ejphar.2022.175214_bib80","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.neuron.2018.08.044","article-title":"Kappa opioid receptor distribution and function in primary afferents","volume":"99","author":"Snyder","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2022.175214_bib81","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1111\/bph.13854","article-title":"Selective \u03ba receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice","volume":"174","author":"Spetea","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2022.175214_bib82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2019.05.026","article-title":"Salvinorin A attenuates early brain injury through PI3K\/Akt pathway after subarachnoid hemorrhage in rat","volume":"1719","author":"Sun","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2022.175214_bib83","doi-asserted-by":"crossref","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","author":"Tabit","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ejphar.2022.175214_bib84","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/jpet.102.038703","article-title":"Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats","volume":"304","author":"Vale","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2022.175214_bib85","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain \u2014 misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2022.175214_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/j.1527-3458.2003.tb00248.x","article-title":"A review of the properties of spiradoline: a potent and selective \u03ba-opioid receptor agonist","author":"Wadenberg","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.ejphar.2022.175214_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/aps.2010.138","article-title":"The role of K-opioid receptor activation in mediating antinociception and addiction","author":"Wang","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejphar.2022.175214_bib88","article-title":"Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression","author":"W\u0229glarz","year":"2003","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.ejphar.2022.175214_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2010.03281.x","article-title":"The anti-inflammatory effects of interleukin-4 are not mediated by suppressor of cytokine signalling-1 (SOCS1)","author":"Woodward","year":"2010","journal-title":"Immunology"},{"key":"10.1016\/j.ejphar.2022.175214_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106056","article-title":"Naltrexone (NTX) relieves inflammation in the collagen-induced- arthritis (CIA) rat models through regulating TLR4\/NF\u03baB signaling pathway","volume":"79","author":"Xu","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2022.175214_bib91","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-021-05965-x","article-title":"The kappa-opioid receptor agonist, triazole 1.1, reduces oxycodone self-administration and enhances oxycodone-induced thermal antinociception in male rats","author":"Zamarripa","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2022.175214_bib92","first-page":"1","article-title":"Chronic pain and high-impact chronic pain among U.S. Adults, 2019","author":"Zelaya","year":"2020","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.ejphar.2022.175214_bib93","doi-asserted-by":"crossref","DOI":"10.1186\/s12902-015-0004-7","article-title":"Activation of \u03ba-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats","volume":"15","author":"Zhou","year":"2015","journal-title":"BMC Endocr. Disord."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:07:11Z","timestamp":1777406831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922004757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":93,"alternative-id":["S0014299922004757"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175214","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of kappa opioid receptors in immune system \u2013 An overview","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175214"}}